Citius Pharmaceuticals Names Myron Holubiak To Board
This article was originally published in Scrip
Executive Summary
Citius Pharmaceuticals has appointed former president of Roche Laboratories, Inc., USA, Myron Holubiak to its board – effective Oct. 1, 2015. Prior to being president, Holubiak held sales and marketing positions at Roche. Currently he is chair of the board at BioScrip, Inc., a member of the board of Assembly Biosciences, Inc.; and its predecessor Ventrus Biosciences, Inc.; and is also a founder of Leonard-Meron Biosciences, Inc., as well as its director and CEO.